Interval Colorectal Cancer 전임의 남지혁 -2015.11.23-. Comparison of the Observed Incidence of Colorectal Cancer in the National Polyp Study Cohort with That.

Slides:



Advertisements
Similar presentations
A Quality Colonoscopy: Are You Providing One?
Advertisements

T1 colonic carcinoma – Is endoscopic resection sufficient? HC Yip JHGR 21/7/2012.
Polyps – Where do they come from and what do you do with them?!
Colorectal Cancer Screening and Surveillance FDA Advisory Committee March, 2002 David Lieberman MD Chief, Division of Gastroenterology Oregon Health Sciences.
Role of colonoscopy in the treatment of malignant polyps Pathology of malignant colorectal polyps Assessing the risk of residual disease post-polypectomy.
Treatment of large and giant colorectal polyps in the real world Stéphanie HUSSON, Guy VENTRE, Frédéric VAGNE, Jean François VIES, Marjorie MUSSO, Jean.
Colorectal Adenomas Santhat Nivatvongs MD Mayo Clinic Rochester Minnesota U. S.A.
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.
The Adenoma/Carcinoma Sequence in the Colon
EQUIP Training session 1
Surveillance colonoscopy after polypectomy – how frequent? Dr Chu Ming Leong Tuen Mun Hospital 1.
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
Multitarget Stool DNA Testing for Colorectal-Cancer Screening NEJM April 3, 2014 Vol 3 Imperiale, T.F. et al Presented by Melissa Spera, MD.
DR Jameel Tariq Miro.  Lifetime incidence 5%  90% of cases occur after age 50  One-third of patients with colorectal cancer die from the disease 
When Is A Colonoscopy Not a Colonoscopy
Joint Hospital Surgical Grand Round 19 June 2004.
Update on Colon Cancer Screening and Prevention
Benchmarking For Colonoscopy
High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.
Andreas Adler Charité Medical University of Berlin, Virchow Clinic Campus Central Interdisciplinary Endoscopy Unit Narrow Band versus Conventional Endoscopic.
Colonoscopy; Surveillance Indications
TREATMENT OF LARGE AND GIANT COLORECTAL POLYPS IN THE REAL WORLD UEGW, PARIS, 2007 Association pour le Dépistage du Cancer colorectal dans le Haut-Rhin.
COMPARING YIELD AND COST OF FOBT AND FS IN AN AVERAGE RISK POPULATION: RESULTS AFTER 2 SCREENING ROUNDS N.Segnan MD, Ms Epi Center for Cancer Prevention.
Management of Serrated Polyps of Colorectum Eric YF Cheung Department of Surgery, NDH.
COLONOSCOPY QUALITY: FROM ASSESSMENT TO IMPLEMENTATION
Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based fecal occult blood testing: a population-based controlled trial.
Colon polyps Peter Stanich, MD
Brian Cox Research Associate Professor: Cancer epidemiology and screening University of Otago Hugh Adam Cancer Epidemiology Unit Department of Preventive.
Robert E. Schoen, MD MPH Associate Professor of Medicine and Epidemiology Division of Gastroenterology University of Pittsburgh Organizing Colorectal Cancer.
Screening for Colorectal Cancer (CRC) Nov, 2007 A Aljebreen, FRCPC Division of Gastroenterology KKUH, Riyadh.
Serrated Polyps of the Colon Aaron Sinclair, MD University of Kansas School of Medicine – Wichita Department of Family and Community Medicine Wesley Family.
Sessile Serrated Adenomas: A Case Presentation Kevin Witt, PGY3 Justin Whitt, MD IU Health Ball Memorial Family Medicine Residency.
Chromocolonoscopy Sashi Sagi MBBS Asst Prof of Clinical Medicine Indiana University.
Do all colorectal polyps require pathological examination? Aim To assess whether it is possible to omit the pathological examination of some polyps without.
CT Colonography vs Colonoscopy for the Detection of Advanced Neoplasia David H. Kim, M.D., Perry J. Pickhardt, M.D., Andrew J. Taylor, M.D., Winifred K.
High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.
Colorectal Cancer Screening – 2016 Update Howard Zhang, MD Chief of Gastroenterology and Hepatology Summa Health System.
(A) Surveillance colonoscopies for detecting dysplasia and preventing colorectal carcinoma. (B) Management of visible lesions at endoscopy. A visible lesion.
Quality of Colonoscopy Using an endoscopic database to measure and improve quality AAPCE Memphis- November 5, 2011 David Lieberman MD Chief, Division of.
1 Yize R. Wang, MD, PhD, John R. Cangemi, MD, Edward V. Loftus Jr, MD and Michael F. Picco, MD, PhD Am J Gastroenterol 2013;108:444–449 F1 김혁 / Prof. 김효종.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification R1 김진숙 / Prof. 장재영.
GASTROINTESTINAL ENDOSCOPY Volume 78, No. 3 : 2013 F1 김태영
High frequency of early colorectal cancer in inflammatory bowel disease M W M D Lutgens, F P Vleggaar, M E I Schipper, P C F Stokkers, C J van der Woude,
R4 채정민 / Prof 이창균. INTRODUCTION colonoscopy is a widely used screening tool for colorectal cancer adenoma detection rate (ADR) important quality indicator.
Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.
Do we need colonoscopy in patients with gastric adenoma? The risk of colorectal adenoma in patients with gastric adenomas R3 Kim Jungwook Moon Hee Yang,
High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal- Cancer Deaths N ENG J MED ;8 : Ann G. Zauber, Ph.D, Sidney J. Winawer,
USPSTF Colorectal Cancer Screening Guidelines: What’s New?
Clinical process indicators
Cumulative Probability of Developing Colon Cancer in UC Patients
Polypectomy Perforation , Clipping
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Jasper Vleugels PhD-student AMC
Repeat Colonoscopy Recommendations
A Visual Tour of Effective Colonoscopy
Colitis associated cancer: risk and surveillance
Improving Quality Measures for Colonoscopy and CRC Prevention
Feeling Rushed? Does Late Start Time Predict Poor Quality Colonoscopy?
Surveillance of Dysplasia in Inflammatory Bowel Disease: The Gastroenterologist- Pathologist Partnership  David T. Rubin, Jerrold R. Turner  Clinical Gastroenterology.
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Nonpolypoid (Flat and Depressed) Colorectal Neoplasms
A Visual Tour of Effective Colonoscopy
Cesare Hassan, Perry J. Pickhardt, Douglas K. Rex 
Swati G. Patel, Dennis J. Ahnen 
Heiko Pohl, Douglas J. Robertson 
Risks of interval colorectal cancer in a FIT-based screening program
Colonoscopy in crc screening
Presentation transcript:

Interval Colorectal Cancer 전임의 남지혁

Comparison of the Observed Incidence of Colorectal Cancer in the National Polyp Study Cohort with That Expected on the Basis of Data from the Three Reference Groups Winawer SJ et al. N Engl J Med 1993;329:

Clinical Gastroenterology and Hepatology Vol. 12, No. 1 Incidence/mortality of CRC and screening uptake rates over time. CRC incidence/mortality reported as rates among adults age 50 years or older (Surveillance, Epidemiology and End Results database) to reflect the screening population.

Korean J Gastroenterol, Vol. 59 No. 2, February 2012 대장내시경검사 (1)50 세 이상 평균위험군에서 대장암 선별과 대장샘종 진단검사로 대장내시경검 사를 우선적으로 권고한다. (2) 50 세 이상 평균위험군에서 첫 선별대장내시경검사가 일정 질 수준 이상으로 이루어졌다면 대장암이나 대장샘종이발견되지 않은 경우 5 년 이후 추적대장 내시경검사를 권고한다. 단, 대장암 경고증상이 새롭게 발생한 환자를 포함하 여추적기간 내 중간암의 우려가 있다고 의사가 판단하는 경우 5 년 이내라도 추적검사를 시행할 수 있다

일정한 자격을 갖춘 대장내시경의사가 양호한 대장정결상태에서 양질의 기준대 장내시경검사를 시행하였음을 전제로 기준대장내시경검사 소견이 폴립절제 후 진행신생물 발생의 고위험군에 해당되지 않는 경우, 추적대장내시경검사 를폴립절제 후 5 년에 시행할 것을 권고한다. 일정한 자격을 갖춘 대장내시경의사가 양호한 대장정결상태에서 양질의 기준대 장내시경검사를 시행하였음을 전제로 기준대장내시경검사 소견이 폴립절제 후 진행신생물 발생의 고위험군에 해당하는 경우는 추적대장내시경검사를 폴 립절제 후 3 년에 시행할 것을 권고한다. Korean J Gastroenterol 2012;59:99-117

대장 내시경은 대장암 사망률을 감소 시키는가 ? AuthorYearNCRC motalitiy reduction Bxter200910,292(case) 51,460(control) 67% (Lt) 1% (Rt) Singh201054,80329%, 47%(Lt),0%(Rt) Ranbeneck20102,412,0473% decrease/ 1% increase in colonoscopy Zauber20122,60253%

Interval Colorectal Cancer Interval Colorectal Cancer  Postcolonoscopy CRC after colonoscopy(0 - 5 yr) = Interval cnacer  Interval advanced adenoma > 1 CM villous high grade dysplasia

Interval cancer 의 빈도와 호발 위치  Clinical Gastroenterology and Hepatology Vol. 12, No. 1

Interval between last colonoscopy and index admission April 1997 ~ Mar Pt with new right colon cancer 2654 patients had at least 1 colonoscopy with 3 yrs 158 (7%)

중간암이 근위부 대장에 흔한 이유는 ? 중간암이 근위부 대장에 흔한 이유는 ? In the proximal colon  Worse bowel prepration  More incomplete colonoscopies  More difficult to examine ( esp. proximal to the IC valve, hepatic flexure or folds)  Flat lesions are more common

Interval cancer 의 위험인자 Clinical Gastroenterology and Hepatology Vol. 12, No. 1

Patient factor Age: every 10 year increase : OR 1.18(1.08 ~ 1.28) Female(2.28) Diverticulosis(OR 6.0) Positive FOBT (OR 2.93) Prior index colonoscopy Advanced adenoma, villous adenoma, high grade dysplasia Polypectomy (OR4.33), biopsy (2.97) Incomplete colonoscopy (OR 7.24) Endoscopist –related factor Lower polypetomy rate Lower adenoma detection rate Nongastroenterologist/nonsurgeon (OR 1.88, 1.67) Family medicine(OR 1.59) Nonhospital setting(OR 1.88) Rural hospital (OR 2.11) > Urban hospital

Why do Interval cancer occur ?  Why Colorectal Cancers Appear in the Period Shortly After Clearing Colonoscopy Am J Gastroenterol 2006;101:2866–2877

중간암의 원인 분석 Robertson DJ, et al. Gut 2014;63:949–956

중간암의 원인 분석 Interval cancer/ Total participants Missed lesion Incomplete ressection New lesion Failed biopsy Robertson /9,16752% ( 30 )19% ( 11 )24% ( 14 )5% ( 3 ) Huang /1,79436% ( 5 )50% ( 7 )14% ( 2) Pabby /2,07923% ( 3 )30.7% ( 4 )23% ( 3 ) Total85/13, % (38)25,9% (22)22.4% (19)7.0%( 6 )

Characteristics of missed polyp Endoscopy 2008; 40: 284 ± 290

Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic Review The American Journal of Gastroenterology (2006) 101, 343–350

Adenoma miss rate by size [Biliary cystadenocarcinoma of the liver: the need for complete resection, Eur J Cancer Nov; 34(12): ]

Screening Colonoscopies and Detection Rates  6681 screening colonoscopies,15 gastroenterologists, over a 10-year period  11,049 polyps (adenomas(51%) serrated polyps(36%) proximal serrated polyps (11% ) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2011;9:42–46

Rates of Detection of Lesions According to Mean Withdrawal Time N Engl J Med 2006;355: Colonoscopies(2053 screening), 12 experienced gastroenterologists, 15-month

Risk of the Patients with Missed Polyp, Adenoma or Advanced Adenoma by Bowel Preparation Status Clin Endosc 2012;45:

Adenoma 발견률이 높으면 ? 186 endoscopist 45,026 patients 42 interval cancers N Engl J Med 2010; 362:

Complete colonoscopy 와 interval cancer 와 상관 관계 GASTROENTEROLOGY 2011;140:65– ~2005, 14,064 CRC patients 6.8% distal / 12.4% proximal interval cancer Complete colonoscopy : to cecum, to termonal ileum

Missed polyp / cancer Contribute to 44.7% (23-54%) of interval cancer Technical limitations : hidden mucosa, flat lesion Endoscopist – dependent Suboptimal observation techniques/ withdrawal time Incomplete bowel preparation Incomplete colonoscopy ]

폴립의 불완전 절제

중간암의 원인 분석 Interval cancer/ Total participants Missed lesion Incomplete ressection New lesion Failed biopsy Robertson /9,16752% ( 30 )19% ( 11 )24% ( 14 )5% ( 3 ) Huang /1,79436% ( 5 )50% ( 7 )14% ( 2) Pabby /2,07923% ( 3 )30.7% ( 4 )23% ( 3 ) Total85/13, % (38)25,9% (22)22.4% (19)7.0%( 6 )

Pathologically incomplete resection rate : 10.1% (determined by the presence of neoplastic tissues on postpolypectomy biopsy)

Characteristics of incompletely resected polyps Characteristics of incompletely resected polyps

Polyp recurrence after endoscopic mucosal resection of sessile and flat colonic adenomas Dig Dis Sci 2011 Aug;56(8): ] 105 patients 121 flat or sessile adenomas (> 10mm) EMR : 67 piecemeal, 54 En –block Recurrence rate (piecemeal vs En bloc) : 9.9% vs 1.7%

Risk of incomplete resection for individual endoscopist

Incomplete resection of polyp Contribute to 25.9% (19-50%) of interval cancer Large, sessile polyp Piecemeal resection Endoscopist – dependent ]

중간암의 원인 분석 Interval cancer/ Total participants Missed lesion Incomplete ressection New lesion Failed biopsy Robertson /9,16752% ( 30 )19% ( 11 )24% ( 14 )5% ( 3 ) Huang /1,79436% ( 5 )50% ( 7 )14% ( 2) Pabby /2,07923% ( 3 )30.7% ( 4 )23% ( 3 ) Total85/13, % (38)25,9% (22)22.4% (19)7.0%( 6 )

Tumorigenesis of colorectal cancer

Molecular, clinical and morphological features of colorectal cancer

Molecular characteristics Interval CRC vs Noninterval CRC 감사합니다 Dig Dis Sci (2012) 57:913–917

빠르게 성장하는 종양 빠르게 성장하는 종양 Contribute to 22.4% (13-24%) of interval cancer May have different molecular profiles than non interval CRC Rapid growth Molecular diffenrnces Difficult to detect the lesions ] Interval cancer